Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 08, 2026 Filed Sep 10, 2026 20:31 UTC
van Grunsven JasperEVP, CP and NPPO
GrantCommon Stock 8,682 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000272 · wk-form4_1789072310.xml · nonDerivative · entry 1

van Grunsven Jasper · CIK 0002154061 · EVP, CP and NPPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,682

F1 · shares: Restricted stock unit award that vests in installments beginning on 09/08/2027.

Read SEC document
August 28, 2026 Filed Sep 1, 2026 20:39 UTC
Ambrose KristenSVP & Chief Accounting Officer
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000267 · wk-form4_1788295172.xml · nonDerivative · entry 1

Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,624

F1 · shares: Restricted stock unit award that vests on 03/01/2029.

Read SEC document
August 27, 2026 Filed Aug 31, 2026 20:20 UTC GiftCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000261 · wk-form4_1788207608.xml · nonDerivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,000

Read SEC document
July 21, 2026 Filed Jul 23, 2026 20:13 UTC
Sachdev AmitEVP Chief Patient & Ext Af Off
GrantCommon Stock 8,251 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000251 · wk-form4_1784837586.xml · nonDerivative · entry 1

Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,512

F1 · shares: Restricted stock unit award that vests on 03/31/2030.

Read SEC document
July 21, 2026 Filed Jul 23, 2026 20:15 UTC
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
GrantCommon Stock 8,251 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000253 · wk-form4_1784837739.xml · nonDerivative · entry 1

Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,572

F1 · shares: Restricted stock unit award that vests on 03/31/2030.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 20:05 UTC GrantDeferred Stock Units · Derivative 31.56 $475.28 $14,999.84
Disclosure

SEC source: 0000875320-26-000247 · wk-form4_1784318742.xml · derivative · entry 1

Garber Alan M · CIK 0001312907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65.458

Underlying: Common Stock · 31.56 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 20:06 UTC GrantDeferred Stock Units · Derivative 99.941 $475.28 $47,499.96
Disclosure

SEC source: 0000875320-26-000249 · wk-form4_1784318797.xml · derivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,771.807

Underlying: Common Stock · 99.941 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

Read SEC document
July 02, 2026 Filed Jul 7, 2026 20:08 UTC
McKechnie DuncanEVP, Chief Commercial Officer
SaleCommon Stock 1,541 $519.00 $799,779.00
Disclosure

SEC source: 0000875320-26-000243 · wk-form4_1783454880.xml · nonDerivative · entry 1

McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,001

F1 · kind: Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Read SEC document
July 02, 2026 Filed Jul 7, 2026 20:15 UTC
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
SaleCommon Stock 1,500 $524.99 $787,485.00
Disclosure

SEC source: 0000875320-26-000245 · wk-form4_1783455338.xml · nonDerivative · entry 1

Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,321

F1 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.

Read SEC document
July 01, 2026 Filed Jul 6, 2026 20:13 UTC
Liu JoyEVP and Chief Legal Officer
SaleCommon Stock 828 $502.71 $416,243.88
Disclosure

SEC source: 0000875320-26-000241 · wk-form4_1783368787.xml · nonDerivative · entry 1

Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,131

F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:09 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 596 $482.50 $287,570.00
Disclosure

SEC source: 0000875320-26-000239 · wk-form4_1782850180.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,337

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 20:08 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 1,020 $462.17 $471,413.40
Disclosure

SEC source: 0000875320-26-000237 · wk-form4_1782245334.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,933

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:12 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 4,062 $450.00 $1,827,900.00
Disclosure

SEC source: 0000875320-26-000235 · wk-form4_1781727153.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,953

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 20:24 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 1,745 $450.00 $785,250.00
Disclosure

SEC source: 0000875320-26-000233 · wk-form4_1781036661.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,015

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:06 UTC
Liu JoyEVP and Chief Legal Officer
SaleCommon Stock 828 $439.91 $364,245.48
Disclosure

SEC source: 0000875320-26-000230 · wk-form4_1780517191.xml · nonDerivative · entry 1

Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,959

F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 20:04 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 1,974 $450.00 $888,300.00
Disclosure

SEC source: 0000875320-26-000228 · wk-form4_1780430661.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,760

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:04 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 1,354 $453.45 $613,971.30
Disclosure

SEC source: 0000875320-26-000225 · wk-form4_1779221059.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,734

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:05 UTC
Bunnage Mark E.EVP, Chief Scientific Officer
SaleCommon Stock 33 $453.45 $14,963.85
Disclosure

SEC source: 0000875320-26-000226 · wk-form4_1779221100.xml · nonDerivative · entry 1

Bunnage Mark E. · CIK 0002100735 · EVP, Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,284

F1 · kind: Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:10 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 6,988 $450.00 $3,144,600.00
Disclosure

SEC source: 0000875320-26-000222 · wk-form4_1778789402.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,088

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
May 04, 2026 Filed May 5, 2026 20:51 UTC SaleCommon Stock 318 $423.73 $134,746.14
Disclosure

SEC source: 0000875320-26-000175 · wk-form4_1778014276.xml · nonDerivative · entry 2

Bhatia Sangeeta N. · CIK 0001643921 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,924

F2 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:51 UTC GrantCommon Stock 943 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000175 · wk-form4_1778014276.xml · nonDerivative · entry 1

Bhatia Sangeeta N. · CIK 0001643921 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,242

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:54 UTC
CARNEY LLOYDDirector
GrantStock Option (Right to Buy) · Derivative 2,866 $0.00 Strike: $424.45 $0.00
Disclosure

SEC source: 0000875320-26-000177 · wk-form4_1778014467.xml · derivative · entry 1

CARNEY LLOYD · CIK 0001204424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,866

Underlying: Common Stock · 2,866 shares

Expires 2036-04-30

F1 · derivative.exercise_date: Fully vested.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:58 UTC GrantStock Option (Right to Buy) · Derivative 1,433 $0.00 Strike: $424.45 $0.00
Disclosure

SEC source: 0000875320-26-000179 · wk-form4_1778014724.xml · derivative · entry 2

Garber Alan M · CIK 0001312907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,433

Underlying: Common Stock · 1,433 shares

Expires 2036-04-30

F2 · derivative.exercise_date: Fully vested.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:58 UTC GrantCommon Stock 472 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000179 · wk-form4_1778014724.xml · nonDerivative · entry 1

Garber Alan M · CIK 0001312907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,344

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:06 UTC GrantStock Option (Right to Buy) · Derivative 2,866 $0.00 Strike: $424.45 $0.00
Disclosure

SEC source: 0000875320-26-000181 · wk-form4_1778015211.xml · derivative · entry 1

Lagarde Michel · CIK 0001518973 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,866

Underlying: Common Stock · 2,866 shares

Expires 2036-04-30

F1 · derivative.exercise_date: Fully vested.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:11 UTC
Liu JoyEVP and Chief Legal Officer
SaleCommon Stock 1,104 $425.02 $469,222.08
Disclosure

SEC source: 0000875320-26-000183 · wk-form4_1778015480.xml · nonDerivative · entry 1

Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,729

F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:18 UTC GrantDeferred Stock Units · Derivative 796 Not disclosed Not disclosed
Disclosure

SEC source: 0000875320-26-000185 · wk-form4_1778015893.xml · derivative · entry 4

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,787.483

Underlying: Common Stock · 796 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death.

F2 · price: Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2025, Ms. McKenzie deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units.

F3 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death.

F3 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:18 UTC Disposition to issuerCommon Stock 796 Not disclosed Not disclosed
Disclosure

SEC source: 0000875320-26-000185 · wk-form4_1778015893.xml · nonDerivative · entry 2

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,378

F2 · price: Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2025, Ms. McKenzie deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:18 UTC GrantCommon Stock 943 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000185 · wk-form4_1778015893.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,174

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:24 UTC GrantStock Option (Right to Buy) · Derivative 2,866 $0.00 Strike: $424.45 $0.00
Disclosure

SEC source: 0000875320-26-000187 · wk-form4_1778016282.xml · derivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,866

Underlying: Common Stock · 2,866 shares

Expires 2036-04-30

F1 · derivative.exercise_date: Fully vested.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:29 UTC GrantDeferred Stock Units · Derivative 796 Not disclosed Not disclosed
Disclosure

SEC source: 0000875320-26-000189 · wk-form4_1778016579.xml · derivative · entry 4

Schneider Jennifer · CIK 0001783060 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 796

Underlying: Common Stock · 796 shares

Expires not disclosed

F4 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death.

F2 · price: Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Dr. Schneider is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units.

F4 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death.

F4 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:29 UTC GrantStock Option (Right to Buy) · Derivative 1,433 $0.00 Strike: $424.45 $0.00
Disclosure

SEC source: 0000875320-26-000189 · wk-form4_1778016579.xml · derivative · entry 3

Schneider Jennifer · CIK 0001783060 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,433

Underlying: Common Stock · 1,433 shares

Expires 2036-04-30

F3 · derivative.exercise_date: Fully vested.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:29 UTC Disposition to issuerCommon Stock 796 Not disclosed Not disclosed
Disclosure

SEC source: 0000875320-26-000189 · wk-form4_1778016579.xml · nonDerivative · entry 2

Schneider Jennifer · CIK 0001783060 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,394

F2 · price: Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Dr. Schneider is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:29 UTC GrantCommon Stock 472 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000189 · wk-form4_1778016579.xml · nonDerivative · entry 1

Schneider Jennifer · CIK 0001783060 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,190

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:37 UTC GrantDeferred Stock Units · Derivative 398 Not disclosed Not disclosed
Disclosure

SEC source: 0000875320-26-000191 · wk-form4_1778017046.xml · derivative · entry 4

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398

Underlying: Common Stock · 398 shares

Expires not disclosed

F4 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death.

F2 · price: Upon the vesting of restricted stock units granted to Ms. Thornberry on May 1, 2025, Ms. Thornberry deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. Thornberry is reporting the disposition of 398 shares of common stock in exchange for an equal number of deferred stock units.

F4 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death.

F4 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:37 UTC GrantStock Option (Right to Buy) · Derivative 1,433 $0.00 Strike: $424.45 $0.00
Disclosure

SEC source: 0000875320-26-000191 · wk-form4_1778017046.xml · derivative · entry 3

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,433

Underlying: Common Stock · 1,433 shares

Expires 2036-04-30

F3 · derivative.exercise_date: Fully vested.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:37 UTC Disposition to issuerCommon Stock 398 Not disclosed Not disclosed
Disclosure

SEC source: 0000875320-26-000191 · wk-form4_1778017046.xml · nonDerivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,109

F2 · price: Upon the vesting of restricted stock units granted to Ms. Thornberry on May 1, 2025, Ms. Thornberry deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. Thornberry is reporting the disposition of 398 shares of common stock in exchange for an equal number of deferred stock units.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:37 UTC GrantCommon Stock 472 $0.00 $0.00
Disclosure

SEC source: 0000875320-26-000191 · wk-form4_1778017046.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,507

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:44 UTC GrantDeferred Stock Units · Derivative 796 Not disclosed Not disclosed
Disclosure

SEC source: 0000875320-26-000193 · wk-form4_1778017445.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,595.156

Underlying: Common Stock · 796 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · price: Upon the vesting of restricted stock units granted to Mr. Upadhyay on May 1, 2025, Mr. Upadhyay deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Mr. Upadhyay is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units.

F3 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F3 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:44 UTC GrantStock Option (Right to Buy) · Derivative 2,866 $0.00 Strike: $424.45 $0.00
Disclosure

SEC source: 0000875320-26-000193 · wk-form4_1778017445.xml · derivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,866

Underlying: Common Stock · 2,866 shares

Expires 2036-04-30

F2 · derivative.exercise_date: Fully vested.

Read SEC document
May 01, 2026 Filed May 5, 2026 21:44 UTC Disposition to issuerCommon Stock 796 Not disclosed Not disclosed
Disclosure

SEC source: 0000875320-26-000193 · wk-form4_1778017445.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558

F1 · price: Upon the vesting of restricted stock units granted to Mr. Upadhyay on May 1, 2025, Mr. Upadhyay deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Mr. Upadhyay is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units.

Read SEC document
April 15, 2026 Filed Apr 17, 2026 20:14 UTC GrantDeferred Stock Units · Derivative 33.898 $442.50 $14,999.87
Disclosure

SEC source: 0000875320-26-000159 · wk-form4_1776456893.xml · derivative · entry 1

Garber Alan M · CIK 0001312907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33.898

Underlying: Common Stock · 33.898 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.

Read SEC document
April 15, 2026 Filed Apr 17, 2026 20:17 UTC GrantDeferred Stock Units · Derivative 107.345 $442.50 $47,500.16
Disclosure

SEC source: 0000875320-26-000161 · wk-form4_1776457052.xml · derivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,671.866

Underlying: Common Stock · 107.345 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

Read SEC document
April 15, 2026 Filed Apr 17, 2026 20:20 UTC GrantDeferred Stock Units · Derivative 80.508 $442.50 $35,624.79
Disclosure

SEC source: 0000875320-26-000163 · wk-form4_1776457233.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,799.156

Underlying: Common Stock · 80.508 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:53 UTC
Liu JoyEVP and Chief Legal Officer
SaleCommon Stock 978 $449.17 $439,288.26
Disclosure

SEC source: 0000875320-26-000157 · wk-form4_1775249628.xml · nonDerivative · entry 1

Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,833

F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Read SEC document
March 27, 2026 Filed Mar 31, 2026 20:10 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 2,329 $450.95 $1,050,262.55
Disclosure

SEC source: 0000875320-26-000149 · wk-form4_1774987818.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,076

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:04 UTC
Bozic CarmenEVP and CMO
SaleCommon Stock 2,329 $481.79 $1,122,088.91
Disclosure

SEC source: 0000875320-26-000140 · wk-form4_1773777858.xml · nonDerivative · entry 1

Bozic Carmen · CIK 0001790029 · EVP and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,405

F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 20:11 UTC
McKechnie DuncanEVP, Chief Commercial Officer
SaleCommon Stock 2,633 $498.42 $1,312,339.86
Disclosure

SEC source: 0000875320-26-000138 · wk-form4_1773432707.xml · nonDerivative · entry 1

McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,489

F1 · kind: Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:05 UTC
McKechnie DuncanEVP, Chief Commercial Officer
SaleCommon Stock 2,437 $475.30 $1,158,306.10
Disclosure

SEC source: 0000875320-26-000136 · wk-form4_1772831152.xml · nonDerivative · entry 1

McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,122

F1 · kind: Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:21 UTC
Liu JoyEVP and Chief Legal Officer
SaleCommon Stock 892 $495.96 $442,396.32
Disclosure

SEC source: 0000875320-26-000134 · wk-form4_1772659274.xml · nonDerivative · entry 1

Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,811

F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.